The lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target
in Congenital Central Hypoventilation Syndrome (CCHS)
A two-year post-doc position on the project entitled “The lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)” founded by the Telethon Foundation, is available at the “Molecular Pharmacology” laboratory (PI Prof. Fornasari), Dept. of Medical Biotechnology and Translational Medicine, University of Milan. The starting date is April 1st, 2023.
This person will join a group working on CCHS syndrome, a life-threating disorders affecting the Autonomic Nervous System and central chemosensitivity, caused by mutations in the PHOX2B gene. The project aims at assessing molecular mechanisms of CCHS pathogenesis by means of healthy and disease-derived iPSCs.
We are seeking for a dynamic and highly motivated research fellow at pre-doctoral stage with a master’s degree in Biological Sciences, Biotechnology or Pharmaceutical Sciences. Good practice in cellular and molecular biology technologies and experience with cell culture is a requisite for applying to this position. Experience with pluripotent stem cell culture will be considered a plus.
Link to the call:
For further information please contact:
Simona Di Lascio – firstname.lastname@example.org
Roberta Benfante – email@example.com
Associate Professor of Pharmacology
Dept. Medical Biotechnology and Translational Medicine
University of Milan
Via Luigi Vanvitelli 32